FDAFDA · Food and drugs·Recall number D-0871-2023
Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30
Published June 21, 2023 · Recall initiated: June 12, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- TRANEXAMIC ACID
- Manufacturer
- Amring Pharmaceuticals Inc
- Distributor
- Nationwide in the USA.
- Lot
- Lots: X220317A and X220318A, exp. date 09/25
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.